Erin Resources (ASX:ERI) announced that MGC Pharmaceuticals has secured the option to acquire a license to grow its proprietary Sativa L Cannabis (Hemp) strain in Namibia.
As quoted in the press release:

The option has been secured through one of the MGC founder’s existing business operations in Namibia which has been awarded the license.  This option has been secured to roll the Namibian production license into MGC’s operations as part of the existing MGC acquisition consideration terms agreed with Erin, for no additional consideration.   The MGC operations and initial production facilities are currently being established in Slovenia, following key commercial license approvals in the region announced on 11 June 2015, to enable the company to grow for up to eight (8) months of the year in the Northern Hemisphere outdoor operations.

Operation highlights:

  • MGC secures option with Namibian company to acquire license to grow Sativa L Cannabis (Hemp)
  • Provides immediate access to low cost growing operation in legal Cannabinoid (CBD) jurisdiction
  • Material impact on near term cashflow‐ potential 50% increase in MGC operating cashflow from 2017
  • Ability to quickly increase to full 12 month production cycle (from current 8 months in Slovenia)
  • Namibian CBD license will permit MGC to grow an unlimited amount of product for processing and trade
  • MGC’s existing CBD import/export license will enable increased target production of CBD resin in Slovenia and distribution under existing and future commercial offtake agreements
  • Forms a key part of MGC’s strategy to establish operations in the Northern and Southern hemispheres ‐ enabling crops to be grown 365 days of the year
  • Accelerates discussions with additional CBD  offtake partners
  • Strong support from the Namibian Government who welcome the investment in the region

Nativ Segev, CEO of MGC Pharmaceuticals, commented:

Securing the option to establish a growing operation in the Southern Hemisphere provides MGC with the ability to become a supplier of CBD extract all year round. By diversifying our operations geographically we will be able to generate cash flow to the business all year round. We also expect to be able to fill orders for CBD in countries where the supply dwindles out of season, making MGC a preferred supplier to many cosmetics and pharmaceuticals companies who require a constant supply of CBD.

Click here to read the full Erin Resources (ASX:ERI) press release.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less